Cor Vasa 2015, 57(4):e245-e250 | DOI: 10.1016/j.crvasa.2015.05.014

The influence of catheter-based renal sympathetic denervation on renal function and renal arteries

Jana Kypusová*, Otakar Jiravský, Igor Nykl, Gabriela Rappová, Marian Branny
Kardiocentrum, Nemocnice Podlesí, Třinec, Česká republika

Objective: Currently investigated non-pharmacological minimally invasive method for the treatment of resistant hypertension is percutaneous denervation of renal sympathetic nerve fibres by radiofrequency catheter-based ablation. We assessed its influence on renal function and renal arteries.

Methods: The first 38 patients treated with catheter-based renal denervation at our centre between September 2011 and December 2012 were included in the study. Changes in renal function and changes in renal artery morphology at 12 months after the procedure have been analyzed.

Results: Mean age was 57.6 ± 11 years, the majority (63.9%) were men. Average estimated glomerular filtration rates (eGF) were 1.25 ml/s/1.73 m2 before denervation and 1.30 ml/s/1.73 m2 12 months after intervention. Changes in eGF did not reach statistical significance. New haemodynamically non-significant renal artery stenosis (40%) has occurred in only one case after procedure.

Conclusion: In agreement with the results of several studies, our findings suggest that renal denervation (RDN) appears to be a safe therapeutic approach.

Keywords: Renal arteries; Renal function; Renal sympathetic denervation; Resistant hypertension

Received: December 17, 2014; Revised: May 18, 2015; Accepted: May 19, 2015; Published: August 1, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kypusová J, Jiravský O, Nykl I, Rappová G, Branny M. The influence of catheter-based renal sympathetic denervation on renal function and renal arteries. Cor Vasa. 2015;57(4):e245-250. doi: 10.1016/j.crvasa.2015.05.014.
Download citation

References

  1. J. Widimský Jr., Renální denervace u arteriální hypertenze, naděje pro nemocné s rezistentní hypertenzí?, Kapitoly z kardiologie 5 (2013) 48-51.
  2. S.G. Worthley, C.P. Tsioufis, M.I. Worthley, et al., Safety and efficacy of a multi-electrode renal sympathetic denervation system in resistant hypertension: the EnligHTN I trial, European Heart Journal 34 (28) (2013) 2132-2140. Go to original source... Go to PubMed...
  3. V. Monhart, Renální denervace, Interní medicína 15 (11-12) (2013) 349-351.
  4. P. Toušek, J. Widimský Jr., J. Rosa, et al., Catheter-based renal denervation versus intensified medical treatment in patients with resistant hypertension: rationale and design of a multicenter randomized study - PRAGUE-15, Cor et Vasa 56 (2014) e235-e239. Go to original source...
  5. M. Santos, H. Carvalho, Renal sympathetic denervation in resistant hypertension, World Journal of Cardiology 5 (2013) 94-101. Go to original source... Go to PubMed...
  6. B. Štrauch, L. Chytil, I. Kurcová, et al., Jak posoudit non-compliance k farmakoterapii u těžké rezistentní hypertenze? Cor et Vasa 53 (2011) 429-432. Go to original source...
  7. R.H. Fagard, Resistant hypertension, Heart 98 (2012) 254-261. Go to original source... Go to PubMed...
  8. T. Pikus, J. Widimský Jr., T. Zelinka, et al., Prevalence a klinická charakteristika rezistentní hypertenze ve specializovaném centru, Cor et Vasa 49 (2007) 351-354. Go to original source...
  9. G. Grassi, Sympathetic neural activity in hypertension and related diseases, American Journal of Hypertension 23 (2010) 1052-1060. Go to original source... Go to PubMed...
  10. G.F. DiBona, Sympathetic nervous system and hypertension, Hypertension 61 (2013) 556-560. Go to original source... Go to PubMed...
  11. G. Parati, M. Esler, The human sympathetic nervous system: its relevance in hypertension and heart failure, European Heart Journal 33 (2012) 1058-1066. Go to original source... Go to PubMed...
  12. R.E. Schmieder, J. Redon, G. Grossi, et al., Písemné stanovisko ESH: renální denervace-intervenční léčba rezistentní hypertenze, Journal of Hypertension 3 (2012) 78-82.
  13. V. Teplan, Renální denervace sympatiku u závažné hypertenze a farmakoterapie ovlivňující aktivitu SNS, Farmakoterapie 9 (2013) 397-402.
  14. P. Widimský, P. Osmančík, J. Widimský Jr., Renální denervace: naděje pro nemocné s refrakterní hypertenzí? Cor et Vasa 53 (2011) 517-521. Go to original source...
  15. V. Teplan, Renální sympatektomie v léčbě závažné hypertenze: katetrizační denervace, farmakoterapie a renální funkce, Interní medicína 15 (2013) 195-200.
  16. M.C. Brandt, F. Mahfoud, S. Reda, et al., Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension, Journal of the American College of Cardiology 59 (2012) 901-909. Go to original source... Go to PubMed...
  17. M. Poloczek, P. Vysočanová, R. Miklík, et al., Renal denervation in the treatment of resistant arterial hypertension and other perspectives, Cor et Vasa 54 (2012) e202-e208. Go to original source...
  18. H. Krum, M. Schlaich, R. Whitbourn, et al., Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study, Lancet 373 (2009) 1275-1281. Go to original source... Go to PubMed...
  19. M.D. Esler, H. Krum, M. Schlaich, et al., Renal sympathetic denervation for treatment of drug-resistant hypertension: one-year results from the Symplicity HTN-2 randomized, controlled trial, Circulation 126 (2012) 2976-2982. Go to original source... Go to PubMed...
  20. Symplicity HTN-1 Investigators, Catheter-based renal sympathetic denervation for resistant hypertension. Durability of blood pressure reduction out to 24 months, Hypertension 57 (2011) 911-917. Go to PubMed...
  21. F. Mahfoud, B. Cremers, J. Janker, et al., Renal hemodynamics and renal function after catheter-based renal sympathetic denervation in patients with resistant hypertension, Hypertension 60 (2012) 419-424. Go to original source... Go to PubMed...
  22. P. Gosain, P.S. Garimella, P.D. Hart, et al., Renal sympathetic denervation for treatment of resistant hypertension: a systemic review, Journal of Clinical Hypertension (Greenwitch) 15 (2013) 75-84. Go to original source... Go to PubMed...
  23. D.L. Bhatt, D.E. Kandzari, W.W. O'Neill, et al., A controlled trial of renal denervation for resistant hypertension, New England Journal of Medicine 370 (2014) 1393-1401. Go to original source... Go to PubMed...
  24. S.L. Daugherty, J.D. Powers, D.J. Magid, et al., Incidence and prognosis of resistant hypertension in hypertensive patients, Circulation 125 (2012) 1635-1642. Go to original source... Go to PubMed...
  25. R. Holaj, Léčba rezistentní hypertenze, Cor et Vasa 53 (2011) 423-428. Go to original source...
  26. K. Čurila, J. Rosa, P. Toušek, et al., Technical and safety aspects of renal denervation, Cor et Vasa 56 (2014) e228-e234. Go to original source...




Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.